Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Fitch Rates Essex Portfolio L.P.'s $300 Mln Senior Unsecured Notes 'BBB';

RELATED NEWS
Trade ESS now with 
8/10/2012 3:58 PM ET

Fitch Ratings said it has assigned a 'BBB' rating to the $300 million 3.625% senior unsecured notes due August 2022 issued by Essex Portfolio L.P., the operating partnership of Essex Property Trust, Inc. (ESS: Quote).

The unsecured notes were issued at 98.99% of par to yield 3.747%. The company expects to use the proceeds to repay balances on its unsecured line of credit and for general corporate purposes.

Fitch currently rates Essex Property Trust, Inc's Issuer Default Rating or IDR at 'BBB' and Preferred stock 'BB+'.

Click here to receive FREE breaking news email alerts for Essex Property Trust Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After showing a lack of direction throughout much of the session, stocks ended Monday's trading modestly lower. The slightly lower close on the day partly offset the strength that was seen in the markets last week. The major averages ended the day below the unchanged line but off their lows for the session. President Barack Obama reportedly plans to deliver a much-anticipated speech on Thursday outlining his administration's evolving counterterrorism policies. Multiple news sources cited a White House official as saying that Obama will address the use of drones and plans to close the detention facility at Guantanamo Bay in a speech at the National Defense University. A second union representing immigration enforcement officers has expressed opposition to the Senate version of comprehensive immigration reform legislation, arguing that the bill fails to address the "insurmountable bureaucracy" at the agency that oversees lawful immigration to the U.S.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.